Cargando…
Nucleic Acid–Based Therapies for Atherosclerosis
PURPOSE OF REVIEW: Atherosclerosis is characterized by accumulation of lipids and chronic inflammation in medium size to large arteries. Recently, RNA-based antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) are being developed, along with small molecule-based drugs and monoclonal...
Autores principales: | Mäkinen, Petri, Ruotsalainen, Anna-Kaisa, Ylä-Herttuala, Seppo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007442/ https://www.ncbi.nlm.nih.gov/pubmed/32034521 http://dx.doi.org/10.1007/s11883-020-0826-2 |
Ejemplares similares
-
Novel RNAi-Based Therapies for Atherosclerosis
por: Ruotsalainen, Anna-Kaisa, et al.
Publicado: (2021) -
The Long Non-coding Road to Atherosclerosis
por: Josefs, Tatjana, et al.
Publicado: (2020) -
MicroRNAs as Biomarkers for Myocardial Infarction
por: Salic, Kanita, et al.
Publicado: (2012) -
Sortilin as a Regulator of Lipoprotein Metabolism
por: Strong, Alanna, et al.
Publicado: (2012) -
Genetics of Triglycerides and the Risk of Atherosclerosis
por: Dron, Jacqueline S., et al.
Publicado: (2017)